Autologous T cells lentivirally transduced to express L1CAM-specific chimeric antigen receptors (L1CAM-CAR T cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous T cells lentivirally transduced to express L1CAM-specific chimeric antigen receptors (L1CAM-CAR T cells), covering 2025-04-01 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer [Phase 1]